Descriptor English: | Cefotetan | ||||
Descriptor Spanish: |
Cefotetán
| ||||
Descriptor Portuguese: | Cefotetan | ||||
Descriptor French: | Céfotétan | ||||
Entry term(s): |
Apacef Apatef Cefotan Cefotetan Disodium Cefotetan Disodium Salt Ceftotan Disodium Salt, Cefotetan Disodium, Cefotetan ICI 156834 ICI-156834 ICI156834 Salt, Cefotetan Disodium YM 09330 YM-09330 YM09330 |
||||
Tree number(s): |
D02.065.589.099.249.250.199 D02.886.665.074.250.199 D03.383.129.617.235 D03.633.100.300.249.250.199 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D015313 | ||||
Scope note: | A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. |
||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Pharm Action: |
Anti-Bacterial Agents |
||||
Registry Number: | 48SPP0PA9Q | ||||
CAS Type 1 Name: | 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7alpha))- | ||||
Previous Indexing: |
Cephamycins (1982-1988) |
||||
Public MeSH Note: | 89 |
||||
History Note: | 89 |
||||
DeCS ID: | 23577 | ||||
Unique ID: | D015313 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 1989/01/01 | ||||
Date of Entry: | 1988/05/31 | ||||
Revision Date: | 2017/05/24 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Cefotetan
- Preferred
Apatef
- Narrower
Cefotetan Disodium
- Narrower
ICI-156834
- Narrower
YM-09330
- Narrower
Apacef
- Narrower
Ceftotan
- Narrower
Concept UI |
M0023580 |
Scope note | A semisynthetic cephamycin antibiotic that is administered intravenously or intramuscularly. The drug is highly resistant to a broad spectrum of beta-lactamases and is active against a wide range of both aerobic and anaerobic gram-positive and gram-negative microorganisms. |
Preferred term | Cefotetan |
Concept UI |
M0477386 |
Preferred term | Apatef |
Concept UI |
M0351043 |
Preferred term | Cefotetan Disodium |
Entry term(s) |
Cefotetan Disodium Salt Disodium Salt, Cefotetan Disodium, Cefotetan Salt, Cefotetan Disodium |
Concept UI |
M0023581 |
Preferred term | ICI-156834 |
Entry term(s) |
ICI 156834 ICI156834 |
Concept UI |
M0351042 |
Preferred term | YM-09330 |
Entry term(s) |
YM 09330 YM09330 |
Concept UI |
M0477387 |
Preferred term | Apacef |
Concept UI |
M0023579 |
Preferred term | Ceftotan |
Entry term(s) |
Cefotan |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey